These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3110729)

  • 1. Dose-response relationship of doxapram in the therapy for refractory idiopathic apnea of prematurity.
    Barrington KJ; Finer NN; Torok-Both G; Jamali F; Coutts RT
    Pediatrics; 1987 Jul; 80(1):22-7. PubMed ID: 3110729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminophylline versus doxapram in idiopathic apnea of prematurity: a double-blind controlled study.
    Eyal F; Alpan G; Sagi E; Glick B; Peleg O; Dgani Y; Arad I
    Pediatrics; 1985 Apr; 75(4):709-13. PubMed ID: 3982903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic effects of doxapram in idiopathic apnea of prematurity.
    Barrington KJ; Finer NN; Peters KL; Barton J
    J Pediatr; 1986 Jan; 108(1):124-9. PubMed ID: 3080569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxapram for the initial treatment of idiopathic apnea of prematurity.
    Bairam A; Faulon M; Monin P; Vert P
    Biol Neonate; 1992; 61(4):209-13. PubMed ID: 1610948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose doxapram for apnea unresponsive to aminophylline in very low birthweight infants.
    Brion LP; Vega-Rich C; Reinersman G; Roth P
    J Perinatol; 1991 Dec; 11(4):359-64. PubMed ID: 1770394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic apnoea of prematurity treated with doxapram and aminophylline.
    Sagi E; Eyal F; Alpan G; Patz D; Arad I
    Arch Dis Child; 1984 Mar; 59(3):281-3. PubMed ID: 6424586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative study about the therapeutic effect of theophylline and doxapram in apnoeic disorders].
    Möller JC; Austing A; Püst B; Kohl M; Reiss I; Iven H; Gortner L
    Klin Padiatr; 1999; 211(2):86-91. PubMed ID: 10407818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of doxapram in idiopathic apnea of prematurity.
    Beaudry MA; Bradley JM; Gramlich LM; LeGatt D
    Dev Pharmacol Ther; 1988; 11(2):65-72. PubMed ID: 3371147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity.
    Jamali F; Coutts RT; Malek F; Finer NN; Peliowski A
    Dev Pharmacol Ther; 1991; 16(2):78-82. PubMed ID: 1914782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxapram in the treatment of idiopathic apnea of prematurity unresponsive to aminophylline.
    Alpan G; Eyal F; Sagi E; Springer C; Patz D; Goder K
    J Pediatr; 1984 Apr; 104(4):634-7. PubMed ID: 6707826
    [No Abstract]   [Full Text] [Related]  

  • 11. Doxapram in the treatment of idiopathic apnea of prematurity: desirable dosage and serum concentrations.
    Hayakawa F; Hakamada S; Kuno K; Nakashima T; Miyachi Y
    J Pediatr; 1986 Jul; 109(1):138-40. PubMed ID: 3723234
    [No Abstract]   [Full Text] [Related]  

  • 12. Brain hemodynamic effects of doxapram in preterm infants.
    Dani C; Bertini G; Pezzati M; Pratesi S; Filippi L; Tronchin M; Rubaltelli FF
    Biol Neonate; 2006; 89(2):69-74. PubMed ID: 16158005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of the efficacy of aminophylline and doxapram in preventing idiopathic apnea in preterm newborn infants].
    Romeo MG; Proto N; Tina LG; Parisi MG; Distefano G
    Pediatr Med Chir; 1991; 13(1):77-81. PubMed ID: 2052460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxapram versus methylxanthine for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000075. PubMed ID: 10796115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose doxapram therapy in premature infants and its CSF and serum concentrations.
    Kumita H; Mizuno S; Shinohara M; Ichikawa T; Yamazaki T
    Acta Paediatr Scand; 1991; 80(8-9):786-91. PubMed ID: 1957596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral administration of doxapram in preterm neonates with aminophylline-resistant idiopathic apnea crisis].
    Romeo MG; Betta P; Tina LG; Cilauro S; Saporito A; Distefano G
    Pediatr Med Chir; 1995; 17(2):123-6. PubMed ID: 7610073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of apnea of prematurity with aminophylline.
    Bednarek FJ; Roloff DW
    Pediatrics; 1976 Sep; 58(3):335-9. PubMed ID: 958760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal absorption of doxapram in neonates.
    Bairam A; Akramoff-Gershan L; Beharry K; Laudignon N; Papageorgiou A; Aranda JV
    Am J Perinatol; 1991 Mar; 8(2):110-3. PubMed ID: 2006935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data.
    Jamali F; Barrington KJ; Finer NN; Coutts RT; Torok-Both GA
    Dev Pharmacol Ther; 1988; 11(5):253-7. PubMed ID: 3191816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity.
    Tay-Uyboco J; Kwiatkowski K; Cates DB; Seifert B; Hasan SU; Rigatto H
    Biol Neonate; 1991; 59(4):190-200. PubMed ID: 2070020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.